Closing Strong: Actinium Pharmaceuticals Inc (ATNM) Ends at 1.82, Down -6.67 from Last Close

Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

After finishing at $1.95 in the prior trading day, Actinium Pharmaceuticals Inc (AMEX: ATNM) closed at $1.82, down -6.67%. In other words, the price has decreased by -$6.67 from its previous closing price. On the day, 1.29 million shares were traded. ATNM stock price reached its highest trading level at $2.08 during the session, while it also had its lowest trading level at $1.76.

Ratios:

Our goal is to gain a better understanding of ATNM by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.95 and its Current Ratio is at 8.95. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.03.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, B. Riley Securities on August 07, 2024, Downgraded its rating to Neutral and sets its target price to $2 from $16 previously.

On May 14, 2024, Stephens started tracking the stock assigning a Overweight rating and target price of $25.

On September 06, 2023, HSBC Securities started tracking the stock assigning a Buy rating and target price of $11.60.HSBC Securities initiated its Buy rating on September 06, 2023, with a $11.60 target price.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ATNM now has a Market Capitalization of 56701008 and an Enterprise Value of -27487036. For the stock, the TTM Price-to-Sale (P/S) ratio is 708.66 while its Price-to-Book (P/B) ratio in mrq is 1.27. Its current Enterprise Value per Revenue stands at -339.346 whereas that against EBITDA is 0.591.

Stock Price History:

Over the past 52 weeks, ATNM has reached a high of $10.24, while it has fallen to a 52-week low of $1.33. The 50-Day Moving Average of the stock is -72.08%, while the 200-Day Moving Average is calculated to be -72.29%.

Shares Statistics:

The stock has traded on average 731.81K shares per day over the past 3-months and 3363470 shares per day over the last 10 days, according to various share statistics. A total of 31.15M shares are outstanding, with a floating share count of 30.03M. Insiders hold about 3.62% of the company’s shares, while institutions hold 25.99% stake in the company. Shares short for ATNM as of 1722384000 were 2466474 with a Short Ratio of 3.37, compared to 1719532800 on 1882216. Therefore, it implies a Short% of Shares Outstanding of 2466474 and a Short% of Float of 8.08.

Most Popular